|
RALGAPA1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.64800000499599E-08 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.5709999996777E-07 |
| Normal-vs-Stage2 |
1.358630E-03 |
| Normal-vs-Stage3 |
1.03610000024013E-07 |
| Normal-vs-Stage4 |
3.21719999996084E-06 |
| Stage1-vs-Stage2 |
8.547600E-01 |
| Stage1-vs-Stage3 |
1.081580E-01 |
| Stage1-vs-Stage4 |
2.672600E-01 |
| Stage2-vs-Stage3 |
3.391000E-01 |
| Stage2-vs-Stage4 |
2.912400E-01 |
| Stage3-vs-Stage4 |
6.685000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.18989999964292E-07 |
| Normal-vs-AfricanAmerican |
4.02489999999922E-05 |
| Normal-vs-Asian |
6.047800E-04 |
| Caucasian-vs-AfricanAmerican |
7.719000E-01 |
| Caucasian-vs-Asian |
2.074400E-01 |
| AfricanAmerican-vs-Asian |
1.889420E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.50740000271333E-08 |
| Normal-vs-Female |
2.159200E-04 |
| Male-vs-Female |
4.972200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.60219999999689E-05 |
| Normal-vs-Extreme_Weight |
3.38850000003443E-06 |
| Normal-vs-Obese |
8.07500000000738E-05 |
| Normal-vs-Extreme_Obese |
2.162400E-03 |
| Normal_Weight-vs-Extreme_Weight |
9.088000E-01 |
| Normal_Weight-vs-Obese |
5.947400E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.679600E-01 |
| Extreme_Weight-vs-Obese |
6.532800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.783200E-01 |
| Obese-vs-Extreme_Obese |
7.851000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.522300E-02 |
| Normal-vs-Age(41-60Yrs) |
1.046800E-04 |
| Normal-vs-Age(61-80Yrs) |
6.76820000045097E-09 |
| Normal-vs-Age(81-100Yrs) |
4.438100E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.954800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.987600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.419600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.972400E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.616200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.063000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
7.81229999999855E-05 |
| Normal-VS-Type2 PRCC |
2.2004953414978E-11 |
| Normal-VS-KIRP CIMP |
1.062210E-01 |
| Normal-VS-Unclassified PRCC |
1.431760E-04 |
| Type1 PRCC-VS-Type2 PRCC |
1.80999999999099E-06 |
| Type1 PRCC-VS-KIRP CIMP |
5.562000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.670390E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.828800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
7.546500E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
8.621800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.09210007493266E-10 |
| Normal-vs-N1 |
8.559000E-04 |
| Normal-vs-N2 |
3.79239999959147E-07 |
| N0-vs-N1 |
1.909410E-01 |
| N0-vs-N2 |
3.123600E-02 |
| N1-vs-N2 |
3.503700E-02 |
|
|
